Journal article

Repeat pneumococcal polysaccharide vaccination does not impair functional immune responses among Indigenous Australians

PV Licciardi, E Hoe, ZQ Toh, A Balloch, S Moberley, P Binks, R Marimla, A Leach, S Skull, K Mulholland, R Andrews

Clinical and Translational Immunology | Published : 2017


Indigenous Australians experience one of the highest rates of pneumococcal disease globally. In the Northern Territory of Australia, a unique government-funded vaccination schedule for Indigenous Australian adults comprising multiple lifetime doses of the pneumococcal polysaccharide vaccine is currently implemented. Despite this programme, rates of pneumococcal disease do not appear to be declining, with concerns raised over the potential for immune hyporesponse associated with the use of this vaccine. We undertook a study to examine the immunogenicity and immune function of a single and repeat pneumococcal polysaccharide vaccination among Indigenous adults compared to non-Indigenous adults...

View full abstract

Citation metrics